Accreditation

Target Audience

This symposium is intended for an international audience of physicians, nurses, social workers, pharmacists and other healthcare provides involved with palliative care of patients.

Description

As presented March 24, 2006 during the 10th International Palliative Medicine Symposium, this activity is designed to introduce new medications to improve subcutaneous medication administration.

Objectives

At the conclusion of this activity, the participant will be able to:

1. Discuss the role of subcutaneous infusions in palliative medicine.
2. Discuss ways to increase the comfort of subcutaneous infusion.

Activity Director

Susan LeGrand, MD, FACP
Director of Education
The Harry R. Horvitz Center for Palliative Medicine
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio USA

Author / Faculty

Charles F. von Gunten, MD, PhD

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Susan LeGrand, MD, FACP — Consulting: Baxter
                                         — Teaching and Speaking: Kyphon

Charles von Gunten, MD, PhD — Consulting: Baxter, Halozyme, Progenics
                                            — Teaching and Speaking: Baxter, Halozyme,                                                  Janssen, Purdue